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Abstract
Hepatitis C virus (HCV) is a highly pathogenic human virus associated with liver fibrosis, steatosis, and cancer. In infected
cells HCV induces oxidative stress. Here, we show that HCV proteins core, E1, E2, NS4B, and NS5A activate antioxidant
defense Nrf2/ARE pathway via several independent mechanisms. This was demonstrated by the analysis of transient co-
expression in Huh7 cells of HCV proteins and luciferase reporters. Expression, controlled by the promoters of stress-response
genes or their minimal Nrf2-responsive elements, was studied using luminescence assay, RT-qPCR and/or Western-blot
analysis. All five proteins induced Nrf2 activation by protein kinase C in response to accumulation of reactive oxygen species
(ROS). In addition, expression of core, E1, E2, NS4B, and NS5A proteins resulted in the activation of Nrf2 in a ROS-
independent manner. The effect of core and NS5A was mediated through casein kinase 2 and phosphoinositide-3 kinase,
whereas those of NS4B, E1, and E2, were not mediated by either PKC, CK2, PI3K, p38, or ERK. Altogether, on the earliest
stage of expression HCV proteins induced a strong up-regulation of the antioxidant defense system. These events may
underlie the harmful effects of HCV-induced oxidative stress during acute stage of hepatitis C.
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Introduction
Hepatitis C virus (HCV) is a human pathogen which has
infected 2–3% population worldwide [1]. In most cases HCV
infection develops into chronic disease often manifested by liver
steatosis and fibrosis, as well as non-liver diseases such as
cryoglobulinemia, glomerulonephritis and others (for example,
see [2,3,4] and references herein). HCV is an oncogenic virus
strongly involved in the induction of hepatocellular carcinoma
(HCC) [5] and possibly also non-Hodgkin lymphoma [6], driven
by a complex yet incompletely understood pattern of virus-host
interactions.
HCV replication induces oxidative stress, a phenomenon
commonin many chronic liver diseases [7,8]. This stress contributes
to insulin and interferon resistance, disorders of iron metabolism,
liver fibrosis and HCC [9,10,11,12,13]. Specifically, virus nucleo-
capsid (core) and nonstructural NS5A proteins elevate the levels of
reactive oxygen species (ROS) through alteration of calcium
homeostasis [14,15]. In addition, HCV proteins can induce
NADPH oxidase 4 (Nox4) launching yet another mechanism of
ROS formation [16,17]. Finally, the glycoproteins E1 and E2 and
the transmembrane protein NS4B induce ER stress and unfolded
protein response [18,19], which has been linked to ROS generation
by activation of ER oxidoreductases [20].
Normally, ROS are neutralized by the low-molecular weight
antioxidants, and ‘‘phase II detoxifying enzymes’’ [21]. Expression
of phase II as well as of the enzymes of antioxidant biosynthesis
(and also of ‘‘phase III efflux transporters’’) is mainly regulated by
NF-E2-related factor 2 (Nrf2). Nrf2 recognizes a conserved
antioxidant response element (ARE) within the promoters of the
responsive genes [22,23]. Regulation of Nrf2 activity is mediated
by its subcellular localization. In the absence of stress, the
transcription factor is sequestered in the cytoplasm by its partner
Keap1 [22,24]. Phosphorylation of Nrf2 leads to their dissociation
and subsequent translocation of Nrf2 to the nucleus [22,23]. Nrf2
phosphorylation is mediated by protein kinase C (PKC),
phosphoinositide-3-kinase (PI3K), mitogen-activated protein ki-
nases (p38 and ERK1/2), and/or casein kinase 2 (CK2)
[24,25,26,27,28]. The input of each of the kinases in Nrf2
activation depends on the cell type and stress stimuli.
The aim of this work was to study oxidative stress induction by
individual HCV proteins at the earliest stage of their expression,
and the involvement of Nrf2/ARE pathway in the reaction to this
stress. This field was completely blank until two very recent but
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24957contradictory publications on the regulation of Nrf2/ARE system
in HCV infected cells [26,29]. Burdette et al revealed that HCV
replication in HCV cell culture system (HCVcc) is accompanied
by activation of Nrf2/ARE pathway which protects cells from
oxidative stress-induced apoptosis [26]. In the same system, an
independent study of Carvajal-Yepes et al evidenced a suppression
of Nrf2 activation [29]. This study suggested that the down-
regulation was due to core and NS3, their combined action
causing the delocalization of small Maf proteins from the nucleus
not allowing the formation of active Nrf2/Maf heterodimers [29].
Both papers described the consequences of HCV replication in
cultured cells, the cooperative effect generated by all viral proteins
2 to 6 days postinfection, with no obvious reasons for the
discrepancy between the results. The field clearly requires further
mechanistic studies.
Here, we present a detailed overview of the oxidative stress
induction with activation of Nrf2/ARE system by individual HCV
proteins during the earliest stage of their expression. We have
observed that five HCV proteins, namely, core, E1, E2, NS4B,
and NS5A, can both induce elevated ROS levels and activate
Nrf2/ARE pathway. The activation, which is partially ROS-
independent, involves different protein kinases. On the overall, the
study unveils the input of individual HCV proteins in induction
and regulation of the oxidative stress response.
Results
Plasmid construction and characterization
To study the effects of HCV proteins on cellular defense system
against oxidative stress, we constructed a set of plasmids expressing
core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B
proteins of HCV genotype 1b derived from Con1 or highly
homologous 274933RU strains. The resulting plasmids were
transfected into Huh7 cells. Transient protein expression was
confirmed by SDS-PAGE and Western blotting (Fig. S1).
The quantification of expression by imaging of immunoblots
using protein-specific antibodies demonstrated that accumulation
of proteins started 16–20 h and reached a plateau at 30–36 h
posttransfection (Fig. S2A and data not shown). The strongest
differences were observed between the expression of NS5A, and
NS5B, and HCV core (Fig. S2A). NS5A and NS5B were expressed
at similar levels (600–700 fg per transfected cell at 30 h
posttransfection), whereas the amount of core protein was
significantly lower (appr. 100 fg per cell).
To study the influence of HCV proteins on regulation of
expression of phase II detoxifying enzymes, we constructed a pP-
ARE reporter plasmid containing a luciferase gene under the
control of SV40 promoter modified to include the minimal ARE
of one of the phase II detoxifying enzyme genes, human NAD
(P)H:quinone oxidoreductase (Nqo1). The resulting plasmid
directed the expression of luciferase in response to oxidative stress
induced by treatment of cells with tretbutylhydroquinone (tBHQ)
or hydrogen peroxide (H2O2), which confirmed the functionality
of ARE element (Fig. S3A).
Five HCV proteins induce oxidative stress in Huh7 cells
The role of individual HCV proteins in induction of oxidative
stress was studied by measuring levels of ROS triggered by
treatment of cells with oxidation-sensitive dye dichlorofluoresceine
diacetate (DCF-DA). Induction of ROS led to an increase of
fluorescence registered by microplate fluorimetry or fluorescence
microscopy (Fig. 1). P7, NS2, NS3, NS4A, and NS5B had no effect
on ROS levels (Fig. 1A). Expression of core and NS5A proteins
induced considerable ROS production, in lines with their earlier
described capacity to cause oxidative stress [14,15]. The effect of
these proteins was observed starting from 18–20 h after transfec-
tion (Fig. S2B) and was specific to these two proteins, since NS5B
expressed at similar levels did not affect cell redox status. Similar
effects were induced by NS5A and core (Fig. 1A) despite the latter
being expressed at 6–7 fold lower level (Fig. S2A) indicating that
core was a stronger ROS inducer. Surprisingly, expression of E1,
E2, and NS4B proteins, not earlier involved in oxidative stress
induction, also elevated ROS levels. In all these cases, induction of
ROS was completely inhibited by pretreatment of cells with ROS
scavenger, pyrollidine dithiocarbamate (PDTC) (Fig. 1B and data
not shown).
Effect of HCV proteins on ARE-dependent expression of
luciferase
The influence of HCV proteins on transcription of ARE-
dependent genes was first studied using ARE-regulated luciferase
reporter plasmid (pP-ARE). Its co-transfection with each of the
plasmids expressing individual HCV proteins revealed that core,
E1, E2, NS4B, and NS5A strongly stimulated luciferase expression
Figure 1. Effect of transient expression of HCV proteins on accumulation of reactive oxygen species (ROS). Transient expression of HCV
core, E1, E2, NS4B, and NS5A proteins in Huh7 cells induced oxidative stress registered by ROS formation detected by fluorometry of DCF-DA-stained
cells (A). Alternatively, ROS were visualized by fluorescence microscopy, as is shown for cells expressing core protein or treated with tBHQ or/and
40 mM ROS scavenger PDTC (B). Cells treated with 100 mM tBHQ (A,B)o rT m( A) are given as positive and DMSO-treated as negative controls. Error
bars indicate SD. *P,0.01 versus DMSO (Tukey-Kramer test).
doi:10.1371/journal.pone.0024957.g001
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induced by the expression of NS3 (Fig. 2A). Surveys of luciferase
activity done during two days posttransfection revealed that ARE-
regulated expression of luciferase started 18 h and reached plateau
28–30 h post-transfection (Fig S2C). As in case of ROS induction,
the difference in ARE-luciferase activation levels was not due to
difference at the levels of HCV protein expression but was protein-
specific since NS5B expressed to the same level as NS5A (and 6–7-
fold more efficiently than core) did not affect the luciferase
expression (Fig. 2A and S2C). Thus, we have shown that HCV
proteins that induce oxidative stress, also up-regulate the luciferase
expression from an ARE-containing promoter.
Maximum luciferase induction was achieved by HCV core.
However, this protein also up-regulated reporter expression from a
basal SV40 promoter of pGL3-promoter vector (Fig. S4A) as was
described earlier [30]. In the case of pP-ARE, the effect of core
protein was partially mediated through ROS, since treatment of
cells with PDTC inhibited induction of SV40-ARE controlled
reporter, while in case of SV40-controlled reporter it was ROS-
independent (Fig. S4B). Other HCV proteins had no effect on the
SV40-directed luciferase expression.
To confirm specific effects of HCV proteins on ARE-dependent
transcription, the experiment was repeated using the native ARE-
containing promoters of Nqo1 and heme oxygenase 1 (HO-1)
genes (plasmids Nqo1-luc and pHOGL3/9.1, respectively). All
HCV proteins that enhanced ARE-regulated transcription from
pP-ARE, also stimulated luciferase expression from Nqo1 and
HO-1 promoters (Fig. 2B). In contrast, p7, NS2, NS3, NS4A, and
NS5B did not affect the activity of Nqo1 and HO-1 promoters
(Fig. 2C). This experiment demonstrated the specific activity of
HCV proteins, particularly on the transcription of ARE-
responsive genes. The lower activation in case of HO-1 as
compared to Nqo1 promoter, could result from the influence of
other regulatory elements or from a non-optimal ratio between
plasmid expressing HCV proteins and reporter vectors in the
transfection.
Effect of HCV proteins on induction of phase II
detoxifying enzymes
The next step of the study was to confirm the effects of HCV
proteins which induced ARE-regulated transcription, on the
expression of phase II detoxifying enzymes HO-1 and Nqo1.
For this, we transfected Huh7 cells with plasmids expressing HCV
proteins, or treated untransfected cells with tBHQ or Tm. Nqo1
and HO-1 mRNA levels were estimated using quantitative RT-
PCR and protein levels, using Western-blot. HCV core, E1, E2,
NS4B, and NS5A proteins as well as the control stress inducers up-
regulated the transcription of HO-1 and Nqo1 genes (Fig. 3A).
Accordingly, HO-1 and Nqo1 protein levels were significantly
higher compared to these in the non-transfected Huh7 cells or cells
transfected with empty pcDNA3.1(+) vector (Fig. 3B). HCV core
initially inhibited transcription of HO-1 gene (see Fig. S5 of effect
Figure 2. Impact of HCV proteins on ARE-dependent luciferase expression. Histograms of the relative luciferase activities detected for Huh7
cells transfected with plasmids encoding HCV protein and reporter plasmids bearing minimal ARE (*P,0.01 versus DMSO; **P=0.03 versus DMSO;
Tukey-Kramer test) (A) or the full-length promoters of HO-1 or Nqo1 genes (B and C) in the presence of HCV proteins expressed transiently: HCV
proteins activating (B) or not influencing (C) transcription from HO-1 and Nqo1; HCV core is given as positive control of transcription activation. Error
bars indicate SD.
doi:10.1371/journal.pone.0024957.g002
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time point (Fig. 3A, 40 h post transfection). Expression of other
HCV proteins (p7, NS2, NS3, NS4A, and NS5B) did not alter
HO-1 and Nqo1 mRNA or protein levels (Fig. 3C,D). The
expression data was concordant with the data on the effects if
HCV proteins on ARE-regulated reporter expression (Fig. 2).
Therefore, we conclude that HCV proteins, which induce
oxidative stress, can also activate the expression of phase II
detoxifying enzymes.
HCV proteins activated ARE-regulated gene expression
through ROS-dependent and –independent
phosphorylation of Nrf2 that lead to its nuclear
translocation
Next, we have investigated the mechanisms by which HCV
proteins modulate ARE-regulated transcription, specifically if
ARE-regulated luciferase expression is ROS-dependent. Treat-
ment of cells with PDTC diminished tBHQ-induced luciferase
expression by almost five-fold indicating a high degree of ROS-
dependence (Fig. 4). In contrast, in cells expressing HCV proteins,
ARE-regulated reporter expression was reduced by ROS
scavenger only partially (by 1.4–1.9 fold), and in case of core,
only 1.3 fold. This indicated that ARE-regulated transcription in
cells expressing HCV proteins occurred also in a ROS-
independent manner. Interestingly, a similar PDTC effect was
observed for Huh7 cells treated with a control ER stress inducer
tunicamycin (Tm) (Fig. 4).
Next, we have investigated the involvement in expression of
ARE-dependent genes of Nrf2 transcription factor. Activation of
Nrf2 is achieved by its translocation from the cytoplasm to the
nucleus [21]. So we separated cytoplasmic and nuclear protein
fractions by the standard procedures (see ‘‘Materials and
Methods’’) and estimated the amount of Nrf2 in each by Western
blotting. Expression of core, E1, E2, NS4B, and NS5A proteins
caused Nrf2 translocation from cytoplasm into the nucleus (Fig. 5).
Similar effects were observed for the control stress inducers tBHQ
and Tm. This verified that activation of the ARE-dependent genes
was concomitant with the activation of Nrf2.
Nrf2 translocation is regulated by the following enzymes: PKC,
PI3K, CK2, p38 and ERK1/2 mitogen-activated protein kinases,
and PERK [24,25,26,27,28,31]. Our next step was to reveal which
cellular protein kinases are involved in ARE-luciferase gene
induction by individual HCV proteins. For this, we have used the
following inhibitors: wortmannin for PI3K, Ro31-8220 for various
isoforms of PKC, Sb239063 for p38 MAPK, Pd98.059 for ERK,
Figure 3. Up-regulation of HO-1 and Nqo1 gene expression by HCV proteins. Histograms of the relative ho-1 and nqo1 mRNA levels in
Huh7 cells expressing HCV proteins, as quantified by RT-qPCR (Error bars indicate SD) (A and C). Western-blot analysis of the expression of HO-1 and
Nqo1 of samples presented in panels A (panel B) and C (panel D). In both panels, Huh7 cells treated with oxidative stress inducer (tBHQ) or ER stress
inducer (Tm) are given as positive and DMSO-treated cells as negative controls, and b-actin was used as an internal control. On panels C and D HCV
core was also used as a positive control.
doi:10.1371/journal.pone.0024957.g003
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tion, and cells were incubated in their presence for additional
10 h. The results are summarized on Fig. 6 (for complete data see
Fig. S6). The inhibitors had little effect on the basal luciferase
expression (Fig. S6A). Under tBHQ-induced oxidative stress,
ARE-luciferase induction required the activity of PKC, although
an inhibitor of CK2 also caused a small but statistically significant
effect (Fig. 6 and Fig. S6B). Noteworthy, PKC was activated by
ROS, since the corresponding inhibitor was inactive in cells
treated with PDTC. In cells expressing core and NS5A, stimu-
lation of ARE-dependent luciferase transcription was mediated via
three kinases: PKC, PI3K, and CK2 (Fig. 6 and Fig. S6C,D).
Wortmannin and DRB inhibited luciferase expression both in the
absence and in the presence of antioxidant PDTC, whereas Ro31-
8220 exhibited the activity only in the absence of PDTC. This
indicated that PKC-mediated activation was ROS-dependent (as
in the case of tBHQ), whereas two other kinases were activated in
a ROS-independent manner. In cells expressing E1, E2, or NS4B
or treated with Tm, luciferase expression was up-regulated by the
ROS-PKC pathway; other inhibitors tested did not exhibit any
notable ROS-dependent or independent effects (Fig. 6 and Fig.
S6E-H). This indicated that the kinases governing ROS-
independent Nrf2 activation by these proteins remain to be found.
Next, we have studied the effects of protein kinase inhibitors on
the expression of phase II detoxifying enzymes HO-1 and Nqo1
and on the localization of Nrf2 on the example of NS5A protein.
We added the same inhibitors to the NS5A-expressing cells and
quantified the levels of HO-1 and Nqo1 mRNA. Here, as above,
the effect of the control inducer of oxidative stress tBHQ on the
transcription of HO-1 and Nqo1 genes was mediated solely by
PKC (Fig. 7A), while the effect of NS5A protein expression was
sensitive to the inhibitors of PKC, CK2, and PI3K (Fig. 7B). In
lines with this, Nrf2 nuclear translocation in NS5A-expressing cells
was partially blocked by PKC, PI3K, and CK2 inhibitors (Fig. 7D),
while in the tBHQ-treated cells it could be completely prevented
only by the PKC inhibitor (Fig. 7C). In a separate experiment,
cells were treated with PDTC to reveal if the activation occurred
also via ROS-independent mechanism. Indeed, PDTC completely
prevented Nrf2 translocation in case of tBHQ, whereas in case of
NS5A the inhibition was only partial (Fig. 7C,D). Thus, NS5A was
involved in the activation of cellular antioxidant defense system
through both ROS-dependent and independent pathways.
Discussion
Since its discovery, HCV-induced oxidative stress has been
implicated in the development of a variety of virus-associated liver
injuries and metabolic disorders [9,10,11,12,13]. Very little,
however, was known about the exact molecular mechanism(s)
behind the induction of HCV-induced oxidative stress and the
Figure 4. Effect of ROS scavenger PDTC on ARE-dependent luciferase expression induced by HCV proteins. Luciferase activity was
measured in lysates of Huh7 cells expressing core, E1, E2, NS4B, or NS5A proteins, pre-treated with PDTC. The cells treated with oxidative stress
inducer (tBHQ) or ER stress inducer (Tm) are given as positive and DMSO-treated cells as negative controls. Error bars indicate SD.
doi:10.1371/journal.pone.0024957.g004
Figure 5. Influence of HCV proteins on Nrf2 subcellular localization. Nrf2 localization was determined by separation of cytoplasmic (c) and
nuclear (n) protein fractions as described in ‘‘Materials and Methods’’ section with subsequent detection of the transcription factor by Western blot
analysis. tBHQ and Tm were used as control stress inducers.
doi:10.1371/journal.pone.0024957.g005
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24957Figure 6. Influence of protein kinases inhibitors on ARE-dependent luciferase expression induced by HCV proteins. Histograms of
relative luciferase activity in Huh7 cells expressing HCV core, E1, E2, NS4B, or NS5A proteins, treated with commercially available inhibitors of PI3K
(wortmannin, Wo), CK2 (DRB), or PKC (Ro 31-8220, Ro). In a parallel experiment the cells were pre-treated with ROS scavenger PDTC. The control cells
were treated with DMSO. Error bars indicate SD.
doi:10.1371/journal.pone.0024957.g006
Figure 7. Effect of protein kinase inhibitors and PDTC on HO-1/Nqo1 gene expression, and Nrf2 localization. (A,B). Histograms of
relative HO-1 and Nqo1 mRNA levels in Huh7 cells treated with tBHQ (A) or expressing NS5A protein (B), treated with the inhibitors of PI3K
(wortmannin, Wo), p38 (SB 239063, Sb), ERK1/2 (PD98,059, Pd), CK2 (DRB), or PKC (Ro 31-8220, Ro), or with ROS scavenger PDTC. Quantification of
HO-1 and Nqo1 mRNA levels was performed by RT-qPCR using b-actin as a loading control (*P,0.01 versus DMSO, and tBHQ-treated cells or DMSO-
treated cells expressing NS5A, respectively). (C,D). Western blot analysis of Nrf2 subcellular localization in the same samples used in panels (A) and
(B).
doi:10.1371/journal.pone.0024957.g007
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studies. The aim of this work was to investigate the molecular
mechanisms underlying oxidative stress and stress response
induced by the individual HCV proteins. Our work on the effects
of the individual proteins developed in parallel to the studies of the
effects of the whole HCV proteome. Recently, Burdette et al
reported activation of this pathway in response to an oxidative
stress induced by HCV replication in the infectious cell system
and, as a consequence, the induction of high levels of phase II
enzymes [26]. Very recently, in the same system, Carvajal-Yepes
et al reported a contradictory data on the suppression of Nrf2/
ARE pathway [29], indicating that a lot in this field is yet
unknown.
The cellular machinery which protects cells against the harmful
effects of reactive oxygen species has been investigated by many
groups using various models that often generated contradictory
results. Most researchers agreed that the expression of several
antioxidant genes in HCV-infected cells is up-regulated as
compared to the naı ¨ve Huh7 cells [32]. However, the actual
levels of enzymes of glutathione homeostasis or of metallothioneins
were reported to be either higher or lower than in uninfected/
untransfected cells [32,33,34]. These and similar discrepancies
could be due to the use of different experimental systems (stable
cell lines vs. HCV infectious culture), or analysis technique (qPCR,
Western-blotting and proteomic analysis vs. Affymetrix Gene
chips). However, the data on Nrf2/ARE regulation in HCVcc
system [26,29] was generated in one and the same system (JFH-1
strain) using similar methodological approaches which does not
explain the controversy in the results obtained. Our study,
elucidating the role of individual viral proteins, fills this gap.
We found that five HCV proteins, namely core, E1, E2, NS4B,
and NS5A, stimulate generation of ROS and activate Nrf2-
mediated gene transcription. The experiments on the activation of
Nrf2/ARE pathway activation using various methods (reporter
assays, RT-qPCR, Western blotting) gave concordant results.
Activation observed in response to core, E1, E2, NS4B, and NS5A
was specific. Other HCV proteins, such as p7, NS2, NS3, NS4A
or NS5B, did not alter the activity of HO-1 or Nqo1 promoters or
of the minimal ARE element, and had no effect on HO-1 and
Nqo1 mRNA and protein levels. The effects of core, E1, E2,
NS4B, and NS5A were observed as early as 18–20 h and lasted for
$40 h post-transfection. An exception was the expression of HO-
1: transcription and translation of this gene was first suppressed,
and then activated (31 and 40 h post-transfection, respectively).
Surprisingly, activation of Nrf2/ARE pathway in case of all these
proteins did not result exclusively from the oxidative stress
signaling, but also from a ROS-independent process. We have
shown that ROS-dependent mechanism of activation of ARE-
dependent genes involves phosphorylation of Nrf2 transcription
factor by PKC, whereas a ROS-independent effect is mediated by
CK2 and PI3K. Noteworthy, HCV core acted as a potent inducer
of oxidative stress and activator of the defense system even when
present in small amounts (due to low levels of transient expression).
Altogether, this demonstrates that HCV proteins trigger activation
of Nrf2/ARE pathway via several (parallel) mechanisms from the
very on-set of their expression.
The activation of Nrf2/ARE pathway appears to be a common
property of HCV of different genotypes, as was demonstrated for
HCV 1b-derived proteins (here) and for the HCV 2a proteome (by
Burdette et al). Our data specify that this activation and the
concomitant oxidative stress may arise from the expression of five
viral proteins, namely core, E1, E2, NS4B, and NS5A. We found
that stress response starts early, and Burdette et al followed it up to
day 6 post infection. Altogether, these results do not support the
down-regulation of ARE-dependent genes by HCV proteins [33].
Neither can we refute the data of Carvajal-Yepes et al [29], since
the suppression they revealed was due to the combined effect of
HCV proteome, namely of core and NS3, whereas we have
worked with individual HCV proteins. These controversy
motivated us to perform additional experiments in which we have
studied the effects on Nrf2/ARE pathway of co-expression of
HCV nonstructural proteins NS3 to NS5B. We revealed that their
simultaneous expression also activated Nrf2 (data not shown),
indicating that Maf relocalization-driven inhibition may dependon
the presence of other/structural HCV proteins, such as core. We
are currently verifying this possibility with a set of experimental
approaches employed here but using HCV protein combinations.
Both our and Burdette et al [26] data indicate that during the
acute phase of HCV infection the levels of antioxidants and of the
phase II antioxidant enzymes may be elevated. The hazardous
processes triggered by oxidative stress occur in the cell in the first
few hours after the on-set of stress reactions (for example [35,36]).
At the early stages, the infected cells may gain the capacity to
protect themselves against the stress insult by enhancing the
expression of antioxidant genes. The latter might be unfavorable
for propagation of HCV that elaborates strategies of reducing
oxidative stress and/or oxidative stress-response. If this is true, the
study of Carvajal-Yepes et al may present an example of such
negative feedback, i.e. the reduction of expression of Nrf2-
dependent genes after the initial activation. This falls in lines with
the increased levels of oxidized glutathione and of other oxidative
stress markers in blood; normal or suppressed levels of antioxidants
and phase II enzymes [37,38]; and elevated sMaf levels in the liver
tissues of chronic hepatitis C patients [29]. It also correlates with
the expression of another Nrf2-dependent gene mrp2 encoding a
hepatocyte transporter which plays an important role in biliary
excretion of bilirubin and glutathione [39,40]. The expression of
mrp2 is up-regulated in cells harboring an HCV replicon [39], but
is suppressed in the liver of chronic HCV carriers [41]. Unfortu-
nately, we were unable to find any published data on the levels of
antioxidants in the acute HCV infection that would support this
concept. Further studies of the changes in Nrf2/ARE pathway
status during transition from acute to chronic infection are
urgently required.
PKC isoforms are responsible for Nrf2 activation in several cell
types including hepatoblastoma HepG2 [27,42]. Our data
demonstrate that they are involved also in the hepatocytes
expressing individual HCV proteins indicating that their effect
on PKC is not specific to the protein. On contrary, both NS5A
[43] and apparently also core [44] can directly activate PI3K, their
effects on Nrf2 translocation are, therefore, protein-specific. The
mechanism of casein kinase 2 activation in cells expressing core or
NS5A proteins is unclear. However, it has been reported that the
activity of this kinase can be affected by several factors including
alteration of calcium homeostasis [45], a known effect induced by
both core and NS5A proteins [46]. In this study we did not reveal
which kinases are involved in the ROS-independent Nrf2
activation in response to E1, E2, and NS4B-induced stress except
for this not being PKC, CK2, PI3K, p38, or ERK (Fig. 6 and Fig.
S6E-G). A possible option is the PKR-like endoplasmic reticulum
kinase (PERK) [31], but experimental proof of this option is
hampered by the lack of commercially available PERK inhibitors.
It is worth noting that our results differ from those obtained by
Burdette et al [26] who found that activation of Nrf2/ARE
pathway by HCV proteins is mediated through p38 and JNK
MAP kinases. These differences could be due to several factors.
One of them is the use of different systems (expression of individual
proteins of genotype 1b vs. infectious HCV of genotype 2a). Also it
HCV Proteins Activate Nrf2/ARE Pathway
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case versus 4 days post-infection in case of [26]. Thirdly, Burdette
et al used PKC inhibitor Go6976 capable of blocking only the
classical enzyme isoforms, not implicated previously in Nrf2
activation. In contrast, we have used a pan-PKC inhibitor Ro31-
8220 and thus were able to detect the effects of the whole PKC
family.
The biological consequences of Nrf2/ARE pathway regulation
are multifacetted. Oxidative stress reactions, if not alleviated,
quickly (within a few hours after stress induction) lead to a cell
death by apoptosis (see, for example, [35,36]). Indeed, when we
inhibited Nrf2/ARE activation with PKC inhibitor, or a
combination of PI3K and CK2 inhibitors 48 h post-transfection,
the cells underwent apoptosis, while cell growth was not altered in
the inhibitor-treated cells transfected with empty vector used as a
control (data not shown). Clearly, the activation of antioxidant
defense system during HCV protein expression, as in acute HCV
infection, can mitigate harmful effects of oxidative stress protecting
affected cells. However, activation of Nrf2/ARE pathway may
also alleviate the ROS-mediated inhibition of virus replication [47]
(actually favoring viral replication) and trigger cell transformation
[26]. This suggests that the use of antioxidants to protect infected
cells during acute hepatitis C may not be advisable. At the same
time, possible inactivation of Nrf2/ARE pathway during the
chronic stage would justify treatment of patients with antioxidants
to protect from the long-term stress effects. Indeed, a pilot trial
revealed that in patients with elevated liver enzyme levels
treatment with a combination of antioxidants helps to alleviate
necro-inflammatory events and normalize liver enzymes [48].
In summary, we have specified the molecular mechanisms of
regulation of Nrf2/ARE pathway by individual HCV proteins
during the initial steps of their expression in Huh7 cells. These
molecular events may contribute to the overall effect of virus
replication on the antioxidant defense system during the acute
stage of the disease. Further studies are required to gain a
systematic understanding of the in-put of oxidative stress into the
pathogenesis of HCV infection and HCV-related disorders.
Materials and Methods
Reagents
Lipofectamine 2000 was purchased from Invitrogen (Carlsbad,
CA, USA), Dulbecco’s modified Eagle medium (DMEM),
nonessential amino acid solution, and antibiotics for cell cultures
were from PanEco (Moscow, Russia). Fetal calf serum (FCS) was
obtained from HyClone (Logan, UT, USA). 29,79-Dichlorofluor-
escein diacetate (DCFH-DA) and ammonium pyrrolidine dithio-
carbamate (PDTC), protein kinase inhibitors 5,6-dichloro-1-beta-
Dribofuranosylbenzimidazole (DRB), Wortmannin, SB 239063,
Ro 31-8220, and PD98,059, protease inhibitor cocktail as well as
other chemicals were purchased from Sigma (St. Louis, MO,
USA), unless otherwise noted. Antibodies to Nrf2 (ab31163), Nqo1
(ab28947), HO-1 (ab13248), HCV protein E2 (ab20852-100),
HCV protein E1 (ab21306-100), HRP-conjugated anti-rabbit and
anti-mouse secondary antibodies were obtained from Abcam
(Cambridge, UK), monoclonal antibodies to core (clone d4), NS4A
(clone 3F12) and NS4B (clone 6B11) proteins were previously
described [49,50]. Antibodies to b-actin (A1978 clone AC-15)
were obtained from Sigma (St. Louis, MO, USA), Hybond-ECL
membrane was supplied by GE Healthcare (Chalfont St. Giles,
UK), ECL detection and Nuclear and Cytoplasmic Extraction
Reagents (NE-PER kit) reagents were obtained from Thermo
Scientific (Rockford, IL, USA). qPCRmix-HS master mix was
from Evrogen (Moscow, Russia). Taq and Pfu DNA polymerases,
restriction enzymes and T4 DNA ligase were from Fermentas
(Vilnius, Lithuania) or from Sibenzyme (Novosibirsk, Russia). All
unmodified oligonucleotides were synthesized by Lytech (Moscow,
Russia), and Taqman probes for qPCR were obtained from Syntol
(Moscow, Russia). Huh7 cells were a kind gift of Prof. R.
Bartenschlager (Heidelberg University, Germany) [51].
Plasmid constructs
Plasmids pCMVcore and pCMVNS3 expressing core protein
and NS3-protease of HCV isolate 274933RU (GenBank:
AF176573) were described in [52]. Genes of E1, E2, p7 NS2,
and NS4A nonstructural proteins were amplified with pairs of
forward and reverse primers (Table S1) from plasmids pEsNS-2-
217 or p4216-5647 (HCV isolate 274933RU), whereas genes of
NS4B, NS5A, and NS5B proteins were amplified from plasmid
pI341/NS3-39/LucUbiNeo-ET (HCV isolate Con1, GenBank:
AJ238799). The obtained DNA fragments were digested with
restriction nucleases (Supplementary table S1) and cloned into
pcDNA3.1(+) vector (Invitrogen) to give target expression plasmids
(pcDNA-E1 to pcDNA-NS5B). To construct the pP-ARE reporter
plasmid bearing ARE of human Nqo1 gene, oligonucleotides
hARE-For and hARE-Rev were phosphorylated with T4 polynu-
cleotide kinase, annealed, and ligated into Kpn1 and NheI sites of
pGL3-promoter vector (Promega, Madison, WI, USA).
Plasmids pLucNQO1 [53] and pHOGL3/9.4 [54] were a kind
gift of Dr. R. Faraonio (Universita ` di Napoli Federico II) and Dr.
Traylor and Dr. Agarwal (The University of Alabama at
Birmingham), respectively.
Expression of HCV proteins in Huh7 cells
Human hepatoma Huh7 cells were maintained in 5% CO2 at
37uC in DMEM with 10% fetal calf serum, 2 mM glutamine,
50 U/ml penicillin and 50 mg/ml streptomycin. Twenty four
hours prior to transfection, cells were seeded in 6-well plates at a
density of 3610
5 cells/well into antibiotic-free DMEM with FCS
and glutamine, and grown to attain 90–95% confluence. On the
next day, for each well, 1 mg of pcDNA-derived plasmid was
added to 250 ml of DMEM, 2 ml of Lipofectamine 2000 was added
to another tube with 250 ml of DMEM, and both solutions were
incubated at room temperature for 5 min, combined and kept for
additional 45 min. The cells were incubated with the transfection
complexes for 4 hours in serum-free medium which was replaced
with DMEM supplemented with FCS and glutamine. Thirty-six
hours after the cells were washed with phosphate-buffered saline
(PBS) and cellular lysates were prepared by incubating in
radioimmune precipitation (RIPA) buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% NP-40, 0.25% sodium deoxycholate,
1 mM PMSF, 1x Protease Inhibitor Cocktail) for 30 min on ice.
The lysates were denatured at 100uC for 5 min in sample buffer,
then subjected to 12% SDS-PAGE and transferred onto a
nitrocellulose Hybond-ECL membrane in 25 mM Tris, 192 mM
glycine and 20% methanol, which was blocked with 5% nonfat
milk in PBS for 1 h at room temperature (RT). Membranes were
probed with the primary antibody: anti-Core antibody (2 mg/ml),
anti-HCV protein E1 antibody (2 mg/ml), anti-HCV protein E2
antibody (2 mg/ml), anti-NS3 serum (1:500), anti-NS4A antibody
(1.6 mg/ml), anti-NS4B antibody (2 mg/ml), anti-NS5A serum
(1:300), anti-NS5B serum (1:500), at 4uC overnight and washed
twice for 10 min with PBST (PBS with 0.5% Tween-20) followed
by incubation with secondary antibody: anti-mouse antibody
(0.5 mg/ml) or anti-rabbit antibody (0.45 mg/ml) for 1 h at RT.
After an additional washing step with PBST, immunoblots were
visualized using ECL detection system.
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The transfection was performed similarly to the described above
with two modifications. Firstly, before transfection the cells were
seeded in 24-well plates at a density of 86104 cells grown to 80–
95% confluence. Secondly, for each well, the transfection
complexes were formed by a mixture of 0.8 ml Lipofectamine
2000 with 0.2 mg of pcDNA-derived plasmid, 0.4 mg of pSV-b-
galactosidase control vector, and 0.2 mg of pGL3-promoter, pP-
ARE, pLucNQO1 or pHOGL3/9.4 plasmids. Luciferase activity
was measured twenty-eight hours after transfection using a
luminometer (Turner Designs). Transfection efficiency was
normalized on the basis of b-galactosidase activity. In order to
determine which protein kinase is responsible for Nrf2 activation,
18 hours after transfection the cells were treated with inhibitors of
PKC (2 mM Ro 31–8220), PI3K (1 mM Wortmannin), p38 (2 mM
SB 239063), ERK (10 mM PD98,059), dissolved in DMSO, or
CK2 (40 mM DRB), dissolved in ethanol.
In all experiments 100 mM tBHQ and 2 mM Tm if not stated
otherwise were used as control inducers of the oxidative or ER
stress, respectively. H2O2 (400 mM) was used as an alternative
oxidative stress inducer only in the initial experiments on pP-ARE
plasmid characterization since it was found to affect cell viability
(Fig. S3B). In addition, when ROS influence on Nrf2 activation
was investigated, antioxidant PDTC was added eighteen hours
after transfection to 40 mM final concentration. Two hours later,
the inhibitors were added to the antioxidant-containing medium.
Measurement of reactive oxygen species
Intracellular reactive oxygen species (ROS) production was
measured by epifluorescence. The Huh7 cells were transfected
with plasmids, expressing HCV proteins as described above. The
growth medium was removed 16, 18, 20, 22, 24 hours after trans-
fection, the cells were incubated in medium containing 25 mM
dichlorofluorescein diacetate (DCFH-DA) at room temperature
for 30 min. The cells were washed 10 times with 500 ml of PBS.
The fluorescence intensities (FLI) were measured in PBS (200 ml)
using Plate CHAMELEON V reader (Hidex Ltd.) with excitation
at 485 nm and with emission at 535 nm.
Quantitative real-time reverse transcription (RT) – PCR
RNA was isolated from 5610
5 cells with PerfectPure RNA
Cultured Cell kit (5Prime) and reverse transcribed using Reverse
Transcription System (Promega) with random hexamer primer
according to manufacturers’ protocol. QPCR was performed using
IQ5 Real-Time PCR Detection System (BioRad). Primer and
probe sequences were as follows: HO-1: 59-CCAGCAACAA-
AGTGCAAGATTC-39 (sense primer), 59-TCACATGGCATAA-
AGCCCTACAG-39 (antisense primer), 59-[Cy5]-TCTCCGAT-
GGGTCCTTACACTCAGCTTTCT-[BHQ2]-39 (probe); Nqo1:
59-GTCATTCTCTGGCCAATTCAGAGT-39 (sense primer), 59-
TTCCAGGATTTGAATTCGGG-39 (antisense primer), 59-[CY5]-
ACTGACATATAGCATGGGCACACTCCAGC-[BHQ2]-39
(probe); b-actin: 59-GATCATTGCTCCTCCTGAGC-39 (sense
primer), 59-ACTCCTGCTTGCTGATCCAC9 (antisense prim-
er), 59- [R6G]-CTCGCTGTCCACCTTCCAGCAGAT-[BHQ-
1]-39 (probe). A standard reaction mixture (50 ml) contained Taq-
man primer/probe combination, cDNA equivalent to 100 ng total
RNA, and qPCRmix-HS master mix. The real-time PCR thermal
conditions for all genes were 55uC for 5 min, 95uC for 10 min,
followed by 40 cycles each at 95uC for 10 s and 57uC for 1 min
(signal collection temperature). Relative quantitative analysis was
carried out by comparing threshold cycle number for target genes
and a reference b-actin mRNA, amplified in separate tubes.
Subcellular protein fractionation and Western blot
analysis
Huh7 cells were transfected with the plasmid coding HCV
protein or pcDNA3.1(+) plasmid. 36 hours after transfection the
cells were harvested and washed twice in PBS. The cytoplasmic
and nuclear fractions were obtained by NE-PER kit according to
manufacturing protocol. Western analysis was performed as
described above. Membranes were probed with primary antibody:
anti-Nrf2 antibody (5 mg/ml), anti-HO1 antibody (2 mg/ml), anti-
Nqo1 antibody (1 mg/ml), anti-actin antibody (1 mg/ml). We used
ECL Pico Substrate (Thermo Scientific) for detection.
Statistical analysis
Statistical analysis was performed with BioStat 2008 software
(AnalystSoft, Vancouver, Canada). All data are presented as
means6SD. Differences between two groups were compared
using paired Student’s t-test. For comparison between multiple
groups, ANOVA followed with Tukey-Kramer post test was
applied. A value p,0.01 was considered as statistically significant.
Supporting Information
Figure S1 Immunoblot analysis of HCV protein expres-
sion in Huh7 cells 36 h posttransfection.
(TIF)
Figure S2 Analysis of protein expression kinetics and of
their influence in ROS production and ARE-luciferase
expression. (A) Accumulation of core, NS5A, and NS5B
proteins in Huh7 cells. (B) Kinetics of accumulation of reactive
oxygen species (ROS) in cells expressing NS5A or core proteins.
(C) Time-course of ARE-dependent luciferase expression in cells
treated with tBHQ or expressing NS5A or core proteins. tBHQ
was added at the time point of 18 h posttransfection of the NS5A-
expressing cells. NS5B protein-expressing cells were used as a
negative control.
(TIF)
Figure S3 Characterization of the constructed ARE-
luciferase reporter plasmid. tBHQ induces ARE-luciferase
expression and shown no notable cytotoxicity. The Huh7 cells
were transfected with ARE-luciferase reporter, treated with
100 mM tBHQ or 400 mMH 2O2, and luciferase activity was
quantified 10 h later (A). Cytotoxicity was measured by standard
MTT test (B). Error bars indicate SD. *P,0.01 versus DMSO
(Tukey-Kramer test).
(TIF)
Figure S4 Expression of core protein activates both
ARE-luciferase (B) and SV40-luciferase (A,B) activity.
The effect on ARE-luciferase is inhibited by PDTC and therefore
is partially mediated by ROS (B). Error bars indicate SD. *P,0.01
versus DMSO (Tukey-Kramer test).
(TIF)
Figure S5 HCV proteins induce expression of HO-1 and
Nqo1 genes 31 h posttransfection. mRNA levels of the
respective genes were measured by RT-qPCR. B-actin was used as
an internal control. Error bars indicate SD.
(TIF)
Figure S6 Influence of protein kinases inhibitors on
ARE-dependent luciferase expression induced by HCV
proteins. HCV proteins induce ARE-luciferase via PKC in a
ROS-dependent, and by PI3K and CK2 in a ROS-independent
manner. Huh7 cells were cotransfected with pP-ARE luciferase
reporter and plasmids expressing individual HCV proteins, treated
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Sb), ERK1/2 (PD98,059, Pd), CK2 (DRB), or PKC (Ro 31-8220,
Ro), and luciferase activity was measured. Error bars indicate SD.
(TIF)
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